3,190 results match your criteria: "Osaka Medical Center[Affiliation]"
J Hum Genet
May 2019
Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Japan.
Background: Persistence of blastemal components after chemotherapy is a marker of poor outcome in Wilms tumor (WT). Recent reports from local Japanese areas have described pre-chemotherapy blastemal predominant type WT to also be a risk factor for relapse. The significance, however, of blastemal predominant WT remains to be evaluated in a larger study.
View Article and Find Full Text PDFJ Hand Surg Asian Pac Vol
March 2019
1 Department of Orthopedic Surgery, Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.
Background: Patients with some thumb polydactyly subtypes are regarded as having a high risk of secondary deformities or poor treatment outcomes. Radially deviated type is one of these subtypes, but its characteristics and definitive treatment outcomes remain unclear. This study aimed to evaluate the pre- and intraoperative findings and surgical outcomes of this subtype.
View Article and Find Full Text PDFInt J Hematol
April 2019
Department of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
We undertook a retrospective study using the national registry data of hematopoietic stem cell transplantation (HSCT) in Japan to investigate the effect of graft source, particularly autologous or allogeneic tissue, on the treatment outcome in patients aged less than 18 years with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL). Survival analysis was conducted on 31 autologous HSCT (auto-HSCT) and 48 allogeneic HSCT (allo-HSCT) recipients between 1990 and 2013. The 5-year survival rates were significantly lower for allo-HSCT compared to auto-HSCT recipients (32% vs.
View Article and Find Full Text PDFInt J Clin Oncol
June 2019
Department of Otorhinolaryngology-Head and Neck Surgery, Osaka University School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
J Obstet Gynaecol Res
May 2019
Department of Obstetrics and Gynecology, National Hospital Organization, Saga Hospital, Saga, Japan.
Aim: The optimal antibiotic regimen for preterm premature rupture of membrane (pPROM) is still unclear. This study aimed to determine the effects of ampicillin-sulbactam (SBT/ABPC) and azithromycin (AZM) on the incidence of bronchopulmonary dysplasia (BPD).
Methods: This retrospective study included women with singleton gestations and a diagnosis of pPROM between 22 and 27 weeks of gestation.
Cancer Sci
March 2019
Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Aflibercept targets vascular endothelial growth factor. The present study involved assessing the efficacy, safety and pharmacokinetics of aflibercept plus 5-fluorouracil/levofolinate/irinotecan (FOLFIRI) as a second-line treatment for metastatic colorectal cancer (mCRC) in Japanese patients. Aflibercept (4 mg/kg) plus FOLFIRI was administered every 2 weeks in 62 patients with mCRC until disease progression, unacceptable toxicity or patient withdrawal.
View Article and Find Full Text PDFPrenat Diagn
January 2019
Division of Fetal Medicine, Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
Oral Radiol
January 2018
Department of Oral Radiology, Osaka Dental University, 1-5-17, Otemae, Chuo-ku, Osaka, 540-0008, Japan.
Background: Use of contrast-enhanced cross-sectional imaging is considered standard practice for investigating mucoepidermoid carcinoma (MEC) in the salivary glands. The purpose of this study was to present the common features of MEC on computed tomography (CT) and magnetic resonance imaging (MRI) without contrast enhancements, and to investigate the possibility of discriminating between MEC and pleomorphic adenoma based on the features observed on both modalities.
Methods: Twenty cases of biopsy-confirmed MEC originating in the salivary glands were reviewed and characterized by two oral and maxillofacial radiologists with regard to the following aspects: detectability, margin, border, encapsulation, content, contrast between lesion and masticator muscle, and bone changes.
Global Spine J
October 2018
Osaka Rosai Hospital, Osaka, Japan.
Study Design: A retrospective study.
Objectives: To investigate surgical outcomes and limitations of decompression surgery for degenerative spondylolisthesis.
Methods: One hundred patients with degenerative spondylolisthesis who underwent decompression surgery alone were included in this study.
Oncologist
March 2019
Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
Endosc Int Open
October 2018
University of Florida, Gainesville, Florida, United States.
A post-endoscopic submucosal dissection (ESD) scar is expected to look homogeneous, however, some patients develop benign polypoid nodule scar (PNS). Incidence of PNS is unknown, yet these scars have direct clinical implications because they may render evaluation of post-ESD neoplastic recurrence difficult. Therefore, we reviewed the clinical experience of 5 ESD referral centers and evaluated their PNS incidence and clinical management.
View Article and Find Full Text PDFAJP Rep
July 2018
Kinki Daigaku Igakubu Daigakuin Igaku Kenkyuka, Osakasayama, Osaka, Japan.
When single ventricle (SV) is complicated with total anomalous pulmonary venous connection (TAPVC), the pulmonary vein obstruction (PVO) occurs at a high rate. There are some patients who died from the lethal PVO (l-PVO) which needed PVO release dead due to severe desaturation within 24 hours after birth. The purpose of this study was to find a predictive marker for l-PVO during the fetal period.
View Article and Find Full Text PDFGenet Med
April 2019
Clinical Genetics, University Hospitals Bristol, Southwell St, Bristol, UK.
Purpose: Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. Within 2 years, the number of patients identified with pathogenic KAT6A variants has rapidly expanded and the full extent and variability of the clinical phenotype has not been reported.
Methods: We obtained data for patients with KAT6A pathogenic variants through three sources: treating clinicians, an online family survey distributed through social media, and a literature review.
J Atheroscler Thromb
March 2004
Hematol Oncol
December 2018
Department of Hematology/Oncology, Higashi Nagoya National Hospital, Nagoya, Japan.
The international staging system (ISS) is the most commonly used risk-stratification system for patients with multiple myeloma (MM) and is determined by serum albumin and β2-microglobulin levels. In the two determinants, β2-microglobulin levels are frequently observed to be elevated in patients with myeloma, particularly in those with renal impairment. In comparison with patients with intact immunoglobulin myeloma, patients with LC myeloma do not necessarily show decreased levels of serum albumin.
View Article and Find Full Text PDFHepatol Res
March 2019
Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.
Aim: Bile acid biosynthesis is strictly regulated under physiological conditions. The expression of fibroblast growth factor (FGF) 19 is induced when bile acids bind to the farnesoid X receptor in the intestinal epithelium. Fibroblast growth factor 19 is then transported by the portal flow, causing transcriptional inhibition of cytochrome P450, family 7, subfamily A, polypeptide 1 (CYP7A1), a key enzyme in bile acid biosynthesis, through the extracellular signal-regulated kinase (ERK) pathway.
View Article and Find Full Text PDFBMC Cancer
July 2018
Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka, Iwate, 020-8505, Japan.
Background: We present the study rationale and design of the JGOG3023 study, an open-label, parallel-arm, randomized, phase II trial that aimed to assess the efficacy and safety of chemotherapy with or without bevacizumab in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who were previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer. We hypothesize that patients treated with a combination of single-agent chemotherapy and bevacizumab will show improved progression-free survival (PFS) compared with those treated with single-agent chemotherapy alone, in the setting beyond disease progression following prior bevacizumab treatment.
Methods/design: A total of 106 patients who have recurrence or progression of ovarian cancer, while receiving chemotherapy or within 6 months after the final dose of platinum, after completing at least three cycles of bevacizumab plus platinum chemotherapy will be randomized in a 1:1 ratio to treatment with single-agent chemotherapy or single-agent chemotherapy combined with bevacizumab.
Pediatr Int
October 2018
Department of Pediatrics, Juntendo University, Faculty of Medicine, Tokyo, Japan.
Background: The aim of this study was to investigate consumer perception of ionic beverage consumption by young children as a potential link to their excessive use.
Methods: We studied parents' awareness of ionic beverages and the current pattern of use in their young children using a self-administered questionnaire.
Results: A total of 424 responses were recorded.
Brain Dev
January 2019
Department of Child Development, Osaka University United Graduate School of Child Development, Suita, Osaka, Japan; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. Electronic address:
Background: Influenza-associated encephalopathy (IAE) is one of the most serious CNS complications of an influenza virus infection, with unclear pathophysiology. Clasmatodendrosis is a complex of morphological changes in astrocytes characterized by fragmentation of the distal processes and swollen cell bodies. Although pathologists in Japan have long been aware of the presence of clasmatodendrosis in IAE brains, no details of the phenomenon have been published to date.
View Article and Find Full Text PDFSci Rep
July 2018
Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
View Article and Find Full Text PDFGastric Cancer
January 2019
Division of Gastroenterology, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
Background: We investigated early tumor shrinkage (ETS) and depth of response (DpR) using data from the G-SOX study comparing S-1 plus oxaliplatin with S-1 plus cisplatin as the first-line treatment for advanced gastric cancer (AGC).
Methods: ETS was determined as % decrease in the sum of the longest diameters of the target lesions at the first evaluation of week 6 compared to baseline. DpR was the maximum % shrinkage during the study treatment.
Nihon Hoshasen Gijutsu Gakkai Zasshi
March 2019
Department of Central Radiology, Osaka City University Hospital.
As the use of filmless examination images, using various systems, has increased, and became common to perform KAKUTEI and save the images. In particular, the use of quality assurance system for images (Kenzo system) has increased to ensure the efficient performance of confirmed image. However, there has been no report showing what kind of function should be used or how to write the specifications of such a function in introducing the Kenzo system.
View Article and Find Full Text PDFVideoGIE
December 2017
Third Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
PLoS One
December 2018
Department of Otolaryngology, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan.
Background: Chemoradiotherapy (CRT) has improved organ preservation or overall survival (OS) of locoregionally advanced head and neck squamous cell cancer (LAHNSCC), but in clinical trials of conventional CRT, increasing CRT intensity has not been shown to improve OS. In the Adjuvant ChemoTherapy with S-1 after curative treatment in patients with Head and Neck Cancer (ACTS-HNC) phase III study, OS of curative locoregional treatments improved more with adjuvant chemotherapy with S-1 (tegafur gimeracil oteracil potassium) than with tegafur/uracil (UFT). ACTS HNC study showed the significant efficacy of S-1 after curative radiotherapy in sub-analysis.
View Article and Find Full Text PDF